Data Published in Leading Peer-Reviewed Publication, Journal of Clinical Medicine JERUSALEM and BURLINGTON, Mass., March 28, 2024 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, announced positive results in a recently published post-marketing study of its Deep Transcranial Magnetic … Continue reading BrainsWay Announces Positive Results in Late-Life Depression Post-Marketing Analysis